ARCHIVES

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

Two “optimists” present different visions for rapid progress in cancer research at American Association for Cancer Research annual meeting. Leland Hartwell advocates genome-like project for molecular diagnostics. Andrew von Eschenbach describes “fantasies, dreams, visions” becoming reality.

April 9, 2004

Also in this 8-page issue: NCI closes its Tobacco Intervention Research Clinic, blaming flat budget, slow accrual.

October 15, 2004

Breast Asymmetry Predicts Breast Cancer, Study Finds

March 31, 2006

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

St. Jude Children’s wins NCI contract for Pediatric Preclinical Testing Program.

November 12, 2004

Without Advance Directives, Families Prolong Treatment

April 27, 2001